71 papers found
Refreshing results…
Trough Plasma Concentrations of Mifepristone Correlate with Psychotic Symptom Reductions: A Review of Three Randomized Clinical Trials
The Relationship Between the Therapeutic Alliance and Treatment Outcome in Two Distinct Psychotherapies for Chronic Depression
Detecting Critical Decision Points in Psychotherapy and Psychotherapy + Medication for Chronic Depression
Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat
Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia
Efficacy and Safety of Mifepristone for the Treatment of Psychotic Depression:
Catastrophizing, depression and pain-related disability
Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats
Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
Preliminary evidence that plasma oxytocin levels are elevated in major depression
Mifepristone Reduces Weight Gain and Improves Metabolic Abnormalities Associated With Risperidone Treatment in Normal Men
Corrigendum to “A Multisite Trial of Mifepristone for the Treatment of Psychotic Depression: A Site-by-Treatment Interaction” [Contemp. Clin. Trials 30 (2009)284–288]
Mifepristone treatment of olanzapine-induced weight gain in healthy men
A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment
Relationships Among Depression, Chronic Pain, Chronic Disabling Pain, and Medical Costs
Psychosocial Predictors of Resilience After the September 11, 2001 Terrorist Attacks:
Meditation with yoga, group therapy with hypnosis, and psychoeducation for long-term depressed mood: a randomized pilot trial
Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial
Reply
Missing publications? Read more about our data sources.